Derprosa Antimicrobial: Effective against coronavirus SARS-CoV-2 (COVID-19) - Printfinishing

** Post below is shared and originally published by Derprosa, can be found here

Trials have shown that after 24 hours there is a reduction of more than 84% of coronavirus SARS-CoV-2 on its surface area compared to a laminating film without our antimicrobial agent.

Derprosa Antimicrobial is the new designation of our Bacterstop film which has been widely considered the best film to prevent infection by bacteria. Now, we set out to verify its effectiveness for viruses by testing with different types of coronavirus. The film was first tested with the feline coronavirus due to availability and capabilities of independent specialized laboratories. Finally, the film was recently tested with the human coronavirus SARS-CoV-2. In both trials, the performance of Derprosa Antimicrobial films has been outstanding.

Test results proved that Derprosa Antimicrobial inhibits proliferation and neutralizes the survival of bacteria and viruses on non-porous surfaces. It has been specifically tested by independent laboratories against the Methicillin-resistant bacteria Staphylococcus Aureus (MRSA) and Escherichia Coli (E-Coli), and the feline coronavirus viruses (FCoV) and human coronavirus (SARS-CoV-2).

Therefore, Derprosa Gloss Antimicrobial and Derprosa Matte Antimicrobial are the best options to ensure the print integrity, provide a glossy or matte finish, and especially—protect those who come in contact with editorial, packaging, or commercial communication pieces in paper support.

These films provide the same properties, machinability, and technical performance as other traditional films. The antimicrobial effect is long-lasting, odourless, harmless to humans, and totally safe.